Luo Wanwan, Zhang Lingmin, Sheng Lingling, Zhang Zhencheng, Yang Zaixing
Department of Laboratory Medicine, Huangyan Hospital of Wenzhou Medical University, Taizhou First People's Hospital, Taizhou, Zhejiang, China.
Diabetol Metab Syndr. 2021 Jan 15;13(1):6. doi: 10.1186/s13098-021-00624-9.
Diabetes mellitus (DM) could be classified as type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), gestational diabetes mellitus (GDM) and others according to etiology and pathology. Diabetic nephropathy (DN) is one of the most serious complications of DM. YKL-40 is a marker of inflammation and some studies have indicated that DM was related with inflammation. The objective of our study is to perform a systematic review and meta-analysis to confirm the relationship between YKL-40 and DM as well as DN.
Pubmed, Embase, CNKI and Chinese wanfang databases were searched for eligible studies by two independent authors. Studies were included in this meta-analysis if they fulfilled the following inclusion criteria: (1) a study involving the role of YKL-40 in DM (or DN) designed as a case-control study or cohort study; (2) the data of serum YKL-40 levels were available; (3) studies were published in English or Chinese. Finally, twenty-five studies were included in this meta-analysis.
Compared with healthy controls, DM patients had significantly higher levels of YKL-40 (DM: SMD = 1.62, 95% CI 1.08 to 2.25, P = 0.000; GDM: SMD = 2.85, 95% CI 1.01 to 4.70, P = 0.002). Additionally, DM patients with different degree of albuminuria had significantly higher levels of YKL-40 compared with healthy controls (normoalbuminuria: SMD = 1.58, 95% CI 0.59 to 2.56, P = 0.002; microalbuminuria: SMD = 2.57, 95% CI 0.92 to 4.22, P = 0.002; macroalbuminuria: SMD = 2.69, 95% CI 1.40 to 3.98, P = 0.000) and serum YKL-40 levels increased with increasing severity of albuminuria among DM patients (microalbuminuria vs normoalbuminuria: SMD = 1.49, 95% CI 0.28 to 2.71, P = 0.016; macroalbuminuria vs microalbuminuria: SMD = 0.93, 95% CI 0.34 to 1.52, P = 0.002).
Our current meta-analysis demonstrates that serum level of YKL-40 is increased in DM and positively associated with the severe degree of albuminuria. Therefore, we suggest that YKL-40 could be considered to be detected, along with other inflammatory markers, if DM, especially DN, is suspected.
糖尿病(DM)根据病因和病理可分为1型糖尿病(T1DM)、2型糖尿病(T2DM)、妊娠期糖尿病(GDM)等。糖尿病肾病(DN)是DM最严重的并发症之一。YKL-40是一种炎症标志物,一些研究表明DM与炎症有关。我们研究的目的是进行系统评价和荟萃分析,以证实YKL-40与DM以及DN之间的关系。
由两位独立作者在Pubmed、Embase、CNKI和中国万方数据库中检索符合条件的研究。如果研究满足以下纳入标准,则纳入本荟萃分析:(1)一项涉及YKL-40在DM(或DN)中作用的研究,设计为病例对照研究或队列研究;(2)有血清YKL-40水平的数据;(3)研究以英文或中文发表。最后,25项研究纳入本荟萃分析。
与健康对照相比,DM患者的YKL-40水平显著更高(DM:标准化均数差(SMD)=1.62,95%可信区间(CI)1.08至2.25,P=0.000;GDM:SMD=2.85,95%CI 1.01至4.70,P=0.002)。此外,与健康对照相比,不同程度蛋白尿的DM患者的YKL-40水平显著更高(正常蛋白尿:SMD=1.58,95%CI 0.59至2.56,P=0.002;微量白蛋白尿:SMD=2.57,95%CI 0.92至4.22,P=0.002;大量白蛋白尿:SMD=2.69,95%CI 1.40至3.98,P=0.000),并且DM患者中血清YKL-40水平随蛋白尿严重程度增加而升高(微量白蛋白尿与正常蛋白尿:SMD=1.49,95%CI 0.28至2.71,P=0.016;大量白蛋白尿与微量白蛋白尿:SMD=0.93,95%CI 0.34至1.52,P=0.002)。
我们目前的荟萃分析表明,DM患者血清YKL-40水平升高,且与蛋白尿严重程度呈正相关。因此,我们建议,如果怀疑患有DM,尤其是DN,可考虑检测YKL-40以及其他炎症标志物。